Bexion Pharmaceuticals
About:
Bexion Pharmaceuticals is a privately-held biotech company focused on the development and commercialization of innovative cures for cancer.
Website: http://www.bexionpharma.com
Twitter/X: bexionpharma
Top Investors: Michael J. Fox Foundation, Keyhorse Capital (KSTC)
Description:
Bexion Pharmaceuticals is developing innovative cures for cancer. Unlike any other potential drug known in development, BXQ-350 has an entirely new and novel mechanism of action. Studies strongly suggest that specific tumor targeting is the result of targeting Phosphatidylserine patches that are characteristic of tumor cells and neovasculature; and that apoptosis results from activation of acid sphingomyelinase, subsequent generation of ceramide, and elevated levels of caspase.
$18M
$1M to $10M
Covington, Kentucky, United States
2006-01-01
bd(AT)bexionpharma.com
Cameron Durrant
11-50
2024-11-14
Private
© 2025 bioDAO.ai